This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Chemical Company, Limited. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Hiroshi Ishimaru: Innovator in Endosseous Implant Technology
Introduction
Hiroshi Ishimaru is a notable inventor based in Niihama, Japan. He has made significant contributions to the field of biomedical engineering, particularly in the development of endosseous implants. His innovative approach has led to advancements that enhance the performance and safety of these medical devices.
Latest Patents
Hiroshi Ishimaru holds a patent for a method of producing endosseous implants. This method involves thermally spraying a ceramic material onto the surface of a metallic core material that has a rough surface, with a maximum surface roughness of 15 to 100 micrometers. This technique results in implants that exhibit excellent characteristics regarding both the metallic and ceramic materials, while also preventing the dissolution of harmful metal ions. The endosseous implants developed through this method are particularly useful for implantation in various bones, including tooth roots and joints in living bodies.
Career Highlights
Ishimaru is associated with Sumitomo Chemical Company, Limited, where he has been able to apply his expertise in materials science and engineering. His work has not only contributed to the company's portfolio but has also advanced the field of implant technology.
Collaborations
Ishimaru has collaborated with notable colleagues such as Masaaki Hama and Keiichirou Watanabe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hiroshi Ishimaru's contributions to the field of endosseous implants demonstrate his commitment to improving medical technology. His innovative methods and collaborations have paved the way for safer and more effective implants, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile